Tymlos 80 MCG dose pen injectr 1.56ML
Ended Awarded
- Contract number
- SPE2DB25FDM29
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,005
Award facts
- Contract value 100% obligated
- $7,005.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $7,005.39 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on September 25, 2025. This delivery order covers the supply of TYMLOS 80 MCG Dose Pen Injectables in 1.56mL units, with an ultimate completion date of September 26, 2025. The award was issued without a set-aside designation, and performance will occur at the vendor's location in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.999 billion contract vehicle that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company's contract portfolio with DLA encompasses an extensive array of pharmaceutical products, including branded and generic prescription drugs, biologics, over-the-counter medications, and specialty injections spanning oncology treatments, contraceptive devices, and vaccine products. With SAM.gov registration dating to 2001 and consistent award history across multiple product categories, DMS Pharmaceutical Group provides direct pharmaceutical distribution services supporting military health facilities and federal healthcare systems nationwide.
Quick answers
Who was awarded contract SPE2DB25FDM29?
SPE2DB25FDM29 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FDM29 worth?
The government has obligated $7,005 on SPE2DB25FDM29.
Is contract SPE2DB25FDM29 an order under another contract?
Yes. SPE2DB25FDM29 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM29 competed?
The extent of competition for SPE2DB25FDM29 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award